香港2014-17三年不同疫苗匹配度下流感疫苗接种对就医疾病的有效性
结果显示对A(H1N1)、B/Yamagata、B/Victoria有效性中等,对A(H3N2)有效性较低。
要点
- 对A(H1N1)的VE为61.6%(95%CI:21.8%,81.1%)
- 对A(H3N2)的VE为26.4%(95%CI:-1.3%,46.6%)
- 对B/Yamagata和B/Victoria的VE分别为67.0%和60.4%
核心结论
- 香港流感疫苗接种对就医流感的有效性为中等,支持疫苗减轻疾病负担的作用;A(H3N2)有效性降低是持续关注的问题。
主要发现
- 2566例中1118例(43.6%)PCR检测流感A或B阳性。
- VE对A(H1N1)为61.6%(95%CI:21.8%,81.1%),对A(H3N2)为26.4%(95%CI:-1.3%,46.6%),对B/Yamagata为67.0%(95%CI:25.9%,85.3%),对B/Victoria为60.4%(95%CI:0.3%,84.3%)。
- 按年龄组VE一般在50-64岁成人中较高,在儿童和老年人中较低。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza vaccination is the most effective intervention to prevent influenza virus infections. Vaccine effectiveness (VE) can vary due to factors such as matching between vaccine strains and prevailing strains, age and other characteristics of the vaccine recipients. OBJECTIVE: To evaluate influenza VE against medically-attended illness in different age groups and against specific influenza types/subtypes in Hong Kong. METHODS: A test-negative study was conducted from December 2014 through August 2017 in 20 outpatient clinics. Patients at least 6 months of age presenting with at least two symptoms of acute respiratory illness, ARI (fever ≥37.8 °C, cough, sore throat, runny nose, headache, myalgia and phlegm) within 72 h of onset were tested for influenza virus by reverse transcription polymerase chain reaction (PCR). Vaccination history was assessed by self-report or medical records at the clinics. VE against medically-attended illness was estimated using conditional logistic regression for influenza PCR result versus vaccination history, matching by calendar time and adjusting for age, age-squared, sex, and chronic medical illness. Additional analyses examined VE by age group and by influenza type/subtype. RESULTS: We enrolled 2566 patients, of whom 1118 (43.6%) tested positive for influenza A or B virus by PCR. Test-positive subjects were generally older, more likely to present with one of the symptoms of ARI, and less likely to receive vaccination against influenza. VE estimates for influenza A(H1N1), A(H3N2), B/Yamagata and B/Victoria were 61.6% (95% confidence interval, CI: 21.8%, 81.1%), 26.4% (95% CI: -1.3%, 46.6%), 67.0% (95% CI: 25.9%, 85.3%), 60.4% (95% CI: 0.3%, 84.3%), respectively. Estimates of VE by age group were generally higher in adults aged 50-64 and lower among children and older adults. CONCLUSIONS: VE against medically-attended influenza was moderate in Hong Kong, confirming the impact of influenza vaccination in reducing disease burden. The reduced VE for influenza A(H3N2) is a continuing concern.
引用
- Tam YH, Ng TWY, Chu DKW, et al. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17. Vaccine. 2018. PMID: 30190121. doi:10.1016/j.vaccine.2018.08.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。